{
  "$schema": "folio-library-entry/v1",
  "id": "10665-44796-ara",
  "blocks": [
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-front-matter",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Front matter",
      "pageStart": 1,
      "pageEnd": 3,
      "target": "../sections/sec-front-matter.md",
      "narrative": null,
      "content": "اﻹﻃﺎر اﻟﺨﺎص\nﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\nﻟﺘﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا \nواﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت\nرواﻟﻔﻮاﺋﺪ اﻷﺧﺮى",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The Arabic title page of WHO's Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﻹﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "pageStart": 3,
      "pageEnd": 5,
      "target": "../sections/sec-000-اﻹﻃﺎر-اﻟﺨﺎص-ﺑﺎﻟﺘﺄﻫﺐ-ﻟﻸﻧﻔﻠﻮﻧﺰا-اﻟﺠﺎﺋﺤﺔ.md",
      "narrative": null,
      "content": "ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\nﻟﺘﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا\nواﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى\nWHO Library Cataloguing-in-Publication Data\nPandemic inﬂuenza preparedness framework for the sharing of inﬂuenza viruses \nand access to vaccines and other beneﬁts.\n1. Inﬂuenza, Human – prevention and control. 2. Inﬂuenza, Human – virology \n3. Orthomyxoviridae – isolation and puriﬁcation. 4. Inﬂuenza vaccines. 5. Pandemics. \n6. Health planning. 7. International cooperation. I. World Health Organization.\nISBN 978 92 4 650308 7 \n \n \n(NLM classiﬁcation: WC 515)\n© ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ١١٠٢\n( أو www.who.int) ﺟﻤﻴﻊ اﻟﺤﻘﻮق ﻣﺤﻔ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The cataloguing and copyright page of the Arabic edition of the Pandemic Influenza Preparedness (PIP) Framework, with ISBN, WHO copyright and standard disclaimers.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌﺤﺘـﻮﻳــﺎت",
      "pageStart": 5,
      "pageEnd": 5,
      "target": "../sections/sec-001-اﳌﺤﺘـﻮﻳــﺎت.md",
      "narrative": null,
      "content": "اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا\n1\n واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى\n3\n \n \n ١– اﳌﺒﺎدئ\n6\n \n  ٢– اﻟﻐﺮض\n7\n ٣– اﻟﻨﻄﺎق\n8\n ٤– اﻟﺘﻌﺎرﻳﻒ واﳌﺼﻄﻠﺤﺎت\n8\n اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\n٤–١ \n \n8\n اﳌﺼﻄﻠﺤﺎت اﻟﺘﻘﻨﻴﺔ اﻷﺧﺮى\n٤–٢ \n \n10\n أﺳامء اﳌﺆﺳﺴﺎت واﳌﻨﻈامت واﻟﻜﻴﺎﻧﺎت\n٤–٣ \n \n11\n اﳌﺼﻄﻠﺤﺎت اﻷﺧﺮى\n٤–٤ \n \n٥– ﻧﻈﺎم اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻣﻦ أﺟﻞ ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The first part of the table of contents, listing the framework's principles, objective, scope, definitions and the virus-sharing system.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔH5N1 ﻣﻦ اﻟﻨﻤﻂ",
      "pageStart": 5,
      "pageEnd": 7,
      "target": "../sections/sec-002-12-وﻓريوﺳﺎت-اﻷﻧﻔﻠﻮﻧﺰا-اﻷﺧﺮى-اﻟﺘﻲ-ﻗﺪ-ﺗﺴﺒﺐ-ﺟﺎﺋﺤﺔ-ﺑ.md",
      "narrative": null,
      "content": "وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔH5N1 ﻣﻦ اﻟﻨﻤﻂ\n12\n اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ\n٥–١ \n \n13\n ﺑﻴﺎﻧﺎت اﳌﺘﻮاﻟﻴﺎت اﻟﺠﻴﻨﻴﺔ\n٥–٢ \n \n13\n آﻟﻴﺎت اﻟﺘﺘﺒﻊ واﻟﺘﺒﻠﻴﻎ\n٥–٣ \n \n14\n ﺻﻴﻎ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد\n٥–٤ \n \n15\n ٦– ﻧﻈﺎم ﺗﺒﺎدل ﻓﻮاﺋﺪ اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\n15\n اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ\n٦–٠ \n \n16\n ﺗﻨﺴﻴﻖ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﻟﻠﺘﺄﻫﺐ واﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\n٦–١ \n \n16\n ﺗﻘﺪﻳﺮ اﺣﺘامﻻت ﺣﺪوث اﻟﺠﺎﺋﺤﺔ واﻟﺘﺼﺪي ﻟﻠﻤﺨﺎﻃﺮ\n٦–٢ \n \n16\n ﺗﻮرﻳﺪ ﻓريوﺳﺎت اﻟﻠﻘﺎﺣﺎت اﳌﺮﺷﺤﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\n٦–٣ \n \n17\n ﺗﻮرﻳﺪ ﻛﻮاﺷﻒ اﻟﺘﺸﺨﻴﺺ وﻟﻮازم اﻻﺧﺘﺒﺎر\n٦–٤ \n \n17\n ﺗﻮرﻳﺪ اﻟﻜﻮاﺷﻒ اﳌﺮﺟﻌﻴﺔ ﻟﺘﺤﺪﻳﺪ ﻓﻌﺎﻟﻴﺔ اﻟﻠﻘﺎﺣﺎت\n٦–٥ \n \n17\n ﺑﻨﺎء ﻗﺪرات اﳌﺨﺘﱪات وﻗﺪرات ﺗ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The rest of the table of contents, covering the virus-sharing provisions, the benefit-sharing system, governance and the annexes, followed by the heading of World Health Assembly resolution WHA64.5 of May 2011.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى",
      "pageStart": 7,
      "pageEnd": 9,
      "target": "../sections/sec-003-اﻟﺘﺄﻫﺐ-ﻟﻸﻧﻔﻠﻮﻧﺰا-اﻟﺠﺎﺋﺤﺔ-ﺗﺒﺎدل-ﻓريوﺳﺎت-اﻷﻧﻔﻠﻮﻧﺰا.md",
      "narrative": null,
      "content": "واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى\n،ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ اﻟﺮاﺑﻌﺔ واﻟﺴﺘﻮن\nوﻗﺪ ﻧﻈﺮت ﰲ ﺗﻘﺮﻳﺮ اﻟﻔﺮﻳﻖ اﻟﻌﺎﻣﻞ اﳌﻔﺘﻮح اﻟﻌﻀﻮﻳﺔ ﻟﻠﺪول اﻷﻋﻀﺎء اﳌﻌﻨﻲ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل \nﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى؛١\nوإذ ﺗﻌﱰف ﺑﺎﻟﻌﻤﻞ اﻟﺬي اﺿﻄﻠﻊ ﺑﻪ اﻟﺮﺋﻴﺴﺎن اﳌﺸﺎرﻛﺎن وأﻋﻀﺎء ﻣﻜﺘﺐ اﻟﻔﺮﻳﻖ اﻟﻌﺎﻣﻞ اﳌﻔﺘﻮح اﻟﻌﻀﻮﻳﺔ؛\nوإذ ﺗﺮﺣﺐ ﺑﺤﺼﻴﻠﺔ ﻋﻤﻞ اﻟﻔﺮﻳﻖ اﻟﻌﺎﻣﻞ اﳌﻔﺘﻮح اﻟﻌﻀﻮﻳﺔ ﻟﻠﺪول اﻷﻋﻀﺎء واﳌﻌﻨﻲ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: \nﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى ﻋﲆ إﻋﺪاد اﻹﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا \nﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى )ا",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "World Health Assembly resolution WHA64.5, which adopts the PIP Framework, recognises industry's role and asks the Director-General to implement, monitor and report on it every two years.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "١– اﳌﺒﺎدئ",
      "pageStart": 9,
      "pageEnd": 12,
      "target": "../sections/sec-004-١-اﳌﺒﺎدئ.md",
      "narrative": null,
      "content": "ﻋﻨﺪﻣﺎ ﻳﺘﻌﻠﻖ اﻷﻣﺮ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ\nاﻷﺧﺮى ﻓﺈن اﻟﺪول اﻷﻋﻀﺎء ﰲ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ:\nﺗﺬﻛﱢﺮ ﺑﻘﺮار ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ج ص ع٠٦–٨٢ ﺑﺸﺄن اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت \n)١( \nاﻷﻧﻔﻠﻮﻧﺰا واﻟﺤﺼﻮل ﻋﲆ اﻟﻠﻘﺎﺣﺎت وﻏري ذﻟﻚ ﻣﻦ اﻟﻔﻮاﺋﺪ؛\nوﺗﺸري إﱃ اﺳﺘﻤﺮار اﺣﺘامﻻت ﺣﺪوث ﺟﺎﺋﺤﺔ أﻧﻔﻠﻮﻧﺰا ﻗﺪ ﺗﱰﺗﺐ ﻋﻠﻴﻬﺎ آﺛﺎر ﺻﺤﻴﺔ واﻗﺘﺼﺎدﻳﺔ واﺟﺘامﻋﻴﺔ \n)٢( \nﻣﺪﻣﺮة وﺧﺎﺻﺔ ﻟﻠﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ اﻟﺘﻲ ﺗﻌﺎين ﻣﻦ أﻋﺒﺎء ﻣﺮﺿﻴﺔ أﺛﻘﻞ وﻣﻦ ﺿﻌﻒ أﻛﱪ؛\n وﺳﺎﺋﺮ ﻓريوﺳﺎت H5N1 وﺗﻘﺮ ﺑﺄن اﻟﺪول اﻷﻋﻀﺎء ﻣﻠﺘﺰﻣﺔ ﺑﺄن ﺗﺘﺒﺎدل ﻋﲆ ﻗﺪم اﳌﺴﺎواة اﻟﻔريوس\n)٣( \nاﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﻮاﺋﺢ ﺑﴩﻳﺔ وأن ﺗﺘﺒﺎدل ﻛﺬﻟﻚ اﻟﻔﻮاﺋﺪ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the principles agreed by WHO Member States, recalling earlier resolutions and noting the threat of a pandemic, especially for developing countries. It commits states to share H5N1 and other potential pandemic influenza viruses and their benefits on an equal footing, and recognises the sovereign right over biological resources, the importance of technology transfer and the need to fund access to vaccines in developing countries.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "٢– اﻟﻐﺮض",
      "pageStart": 12,
      "pageEnd": 14,
      "target": "../sections/sec-005-٢-اﻟﻐﺮض.md",
      "narrative": null,
      "content": "إن اﻟﻐﺮض ﻣﻦ ﻫﺬا اﻹﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻫﻮ ﺗﺤﺴني اﻟﺘﺄﻫﺐ واﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\nوﺗﻌﺰﻳﺰ اﻟﺤامﻳﺔ ﻣﻦ اﻧﺘﺸﺎر اﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺑﺘﺤﺴني وﺗﻌﺰﻳﺰ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي \nﻟﻬﺎ ﺗﻮﺧﻴﺎً ﻟﺘﺤﻘﻴﻖ ﻧﻈﺎم ﻓﻌﺎل ﻳﺘﺴﻢ ﺑﺎﻟﻌﺪل واﻟﺸﻔﺎﻓﻴﺔ واﻹﻧﺼﺎف واﻟﻜﻔﺎءة واﳌﺴﺎواة ﻣﻦ أﺟﻞ ﻣﺎ ﻳﲇ:\n وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ H5N1 ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ\n)١( \nﺑﴩﻳﺔ؛\nاﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت وﺗﺒﺎدل اﻟﻔﻮاﺋﺪ اﻷﺧﺮى.\n)٢( \n٣– اﻟﻨﻄﺎق\n  وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪH5N1 ﻳﻨﻄﺒﻖ ﻫﺬا اﻹﻃﺎر ﻋﲆ ﺗﺒﺎدل اﻟﻔريوﺳﺎت ﻣﻦ اﻟﻨﻤﻂ\n٣–١ \nﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ وﺗﺒﺎدل اﻟﻔﻮاﺋﺪ.\nﻻ ﻳﻨﻄﺒﻖ ﻫﺬا اﻹﻃﺎر ﻋﲆ ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﳌﻮﺳ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States the framework's objective of improving pandemic preparedness through a fair, transparent and equitable system for sharing H5N1 and other potential pandemic viruses and the benefits. It defines its scope as excluding seasonal influenza and non-influenza pathogens.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "٤– اﻟﺘﻌﺎرﻳﻒ واﳌﺼﻄﻠﺤﺎت",
      "pageStart": 14,
      "pageEnd": 16,
      "target": "../sections/sec-006-٤-اﻟﺘﻌﺎرﻳﻒ-واﳌﺼﻄﻠﺤﺎت.md",
      "narrative": null,
      "content": ".ﻷﻏﺮاض ﻫﺬا اﻹﻃﺎر ﺗﻘﺼﺪ ﺑﺎﳌﺼﻄﻠﺤﺎت اﻟﺘﺎﻟﻴﺔ اﳌﻌﺎين اﻟﻮاردة أدﻧﺎه\nاﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\n٤–١ \nﺗﺸﻤﻞ ﻋﺒﺎرة »اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ١«، ﻷﻏﺮاض ﻫﺬا اﻹﻃﺎر )واﻻﺗﻔﺎق \n \nاﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد اﻟﻮارد ﰲ اﳌﻠﺤﻖ واﻻﺧﺘﺼﺎﺻﺎت اﻟﻮاردة ﰲ اﳌﻠﺤﻖ( وآﻟﻴﺔ ﺗﺘﺒﻊ ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا، \n H5N1 اﻟﻌﻴﻨﺎت اﻟﴪﻳﺮﻳﺔ اﻟﺒﴩﻳﺔ،٢ وﻣﻌﺰوﻻت ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻟﺒﴩﻳﺔ ﻣﻦ اﻟﻨﻤﻂ اﻟﱪي\nوﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ، واﻟﻔريوﺳﺎت اﳌﻌﺪﻟﺔ اﻟﺘﻲ ﺗﻘﻮم ﺷﺒﻜﺔ \n و/ أو H5N1 ﻣﺨﺘﱪات اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﺑﺘﺤﻀريﻫﺎ ﻣﻦ ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا\nﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ، ﻟﺘ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines PIP biological materials, such as clinical specimens, wild-type virus isolates and candidate vaccine viruses made by WHO network laboratories, along with other technical terms like wild-type influenza viruses and genetic sequences.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "أﺳامء اﳌﺆﺳﺴﺎت واﳌﻨﻈامت واﻟﻜﻴﺎﻧﺎت",
      "pageStart": 16,
      "pageEnd": 18,
      "target": "../sections/sec-007-أﺳامء-اﳌﺆﺳﺴﺎت-واﳌﻨﻈامت-واﻟﻜﻴﺎﻧﺎت.md",
      "narrative": null,
      "content": "٤–٣ \n»اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ« ﻫﻲ اﳌﺨﺘﱪات اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ ﺗﻌﻴﻨﻬﺎ اﳌﻨﻈﻤﺔ واﻟﺘﻲ ﻣﻘﺮﻫﺎ ﰲ \n \nاﻟﻮﻛﺎﻻت اﻟﺘﻨﻈﻴﻤﻴﺔ اﻟﻮﻃﻨﻴﺔ أو ﺗﻨﺘﺴﺐ إﻟﻴﻬﺎ، وﻟﻬﺎ دور ﺣﺎﺳﻢ ﻋﲆ اﳌﺴﺘﻮى اﻟﻌﺎﳌﻲ ﰲ اﺳﺘﺤﺪاث ﻟﻘﺎﺣﺎت \nاﻷﻧﻔﻠﻮﻧﺰا اﻟﺒﴩﻳﺔ وﺗﻨﻈﻴﻤﻬﺎ وﺗﻮﺣﻴﺪﻫﺎ اﻟﻘﻴﺎﳼ. وﻫﺬه اﳌﺨﺘﱪات ﺗﺸﺎرك ﰲ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ وﻓﻘﺎً ﻻﺧﺘﺼﺎﺻﺎﺗﻬﺎ.\n»ﻣﻨﺘﺠﻮ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا ووﺳﺎﺋﻞ ﺗﺸﺨﻴﺼﻬﺎ واﳌﺴﺘﺤﴬات اﻟﺼﻴﺪﻻﻧﻴﺔ اﳌﻀﺎدة ﻟﻬﺎ« ﻳُﻘﺼﺪ ﺑﻬﻢ \n \nاﻟﻜﻴﺎﻧﺎت اﻟﻌﻤﻮﻣﻴﺔ أو اﻟﺨﺎﺻﺔ مبﺎ ﻓﻴﻬﺎ اﳌﺆﺳﺴﺎت اﻷﻛﺎدميﻴﺔ أو اﻟﻜﻴﺎﻧﺎت اﳌﻤﻠﻮﻛﺔ ﻟﻠﺤﻜﻮﻣﺎت أو اﻟﺘﻲ \nﺗﺪﻋﻤﻬﺎ اﻟﺤﻜﻮﻣﺎت أو اﳌﻨﻈامت اﻟﺘﻲ ﻻ ﺗﺴﺘﻬﺪف اﻟﺮﺑﺢ أو اﻟﻜﻴﺎﻧﺎت اﻟﺘﺠﺎرﻳﺔ اﻟﺘﻲ ﺗﺴﺘﺤﺪث و/ أو \n أو ﻣﻦ اﺳﺘﻌامﻟﻪ أو ﻣﻦ H5N1 ﺗﻨﺘﺞ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻟﺒﴩ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Defines the institutions and entities named in the framework, including essential regulatory laboratories, influenza vaccine, diagnostic and pharmaceutical manufacturers, national influenza centres and WHO's PIP vaccine stockpile.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "٥– ﻧﻈﺎم اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻣﻦ أﺟﻞ ﺗﺒﺎدل وﻓريوﺳﺎت H5N1 ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ",
      "pageStart": 18,
      "pageEnd": 18,
      "target": "../sections/sec-008-٥-ﻧﻈﺎم-اﻟﺘﺄﻫﺐ-ﻟﻸﻧﻔﻠﻮﻧﺰا-اﻟﺠﺎﺋﺤﺔ-ﻣﻦ-أﺟﻞ-ﺗﺒﺎدل-وﻓر.md",
      "narrative": null,
      "content": "وﻓريوﺳﺎت H5N1 ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ\nاﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The heading for section 5 on the PIP system for sharing H5N1 and other potential pandemic influenza viruses.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ",
      "pageStart": 18,
      "pageEnd": 20,
      "target": "../sections/sec-009-اﻷﺣﻜﺎم-اﻟﻌﺎﻣﺔ.md",
      "narrative": null,
      "content": "٥–١ \nﻳﻨﺒﻐﻲ أن ﺗﻮرد اﻟﺪول اﻷﻋﻀﺎء، ﻋﻦ ﻃﺮﻳﻖ ﻣﺮاﻛﺰﻫﺎ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا وﻣﺨﺘﱪاﺗﻬﺎ اﻷﺧﺮى \n٥–١–١ \nاﳌﺮﺧﺺ ﻟﻬﺎ، إﱃ اﳌﺮﻛﺰ اﳌﺘﻌﺎون ﻣﻊ اﳌﻨﻈﻤﺔ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا أو اﳌﺨﺘﱪ اﳌﺮﺟﻌﻲ اﻟﺘﺎﺑﻊ ﻟﻠﻤﻨﻈﻤﺔ \n اﻟﺬي ﺗﺨﺘﺎره دوﻟﺔ اﳌﻨﺸﺄ اﻟﻌﻀﻮ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ H5 واﳌﻌﻨﻲ ﺑﺎﻟﻨﻤﻂ\n H5N1 ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ، اﳌﺄﺧﻮذة ﻣﻦ ﺟﻤﻴﻊ ﺣﺎﻻت اﻹﺻﺎﺑﺔ ﺑﺎﻟﻔريوﺳﺎت ﻣﻦ اﻟﻨﻤﻂ\nوﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ ﺗﻮرﻳﺪاً ﴎﻳﻌﺎً وﻣﻨﺘﻈامً وﻣﻮﻗﻮﺗﺎً \nﺑﻘﺪر اﻹﻣﻜﺎن.\nﺑﺘﻮرﻳﺪ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا، اﳌﺄﺧﻮذة ﻣﻦ اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا \n٥–١–٢ \nواﳌﺨﺘﱪات اﻷﺧﺮى اﳌﺮﺧﺺ ﻟﻬﺎ، إﱃ اﳌﺮاﻛﺰ اﳌﺘﻌﺎوﻧﺔ ﻣﻊ اﳌﻨﻈﻤﺔ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the general provisions for virus sharing, under which Member States send PIP materials from human H5N1 and other potential pandemic cases to WHO collaborating centres or H5 reference laboratories and consent to onward transfer. It also covers genetic sequence data and the traceability mechanism, noting that its terminology has been changed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "ﺻﻴﻎ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد",
      "pageStart": 20,
      "pageEnd": 22,
      "target": "../sections/sec-010-ﺻﻴﻎ-اﻻﺗﻔﺎق-اﳌﻮﺣﺪ-ﻟﻨﻘﻞ-اﳌﻮاد.md",
      "narrative": null,
      "content": "٥–٤ \nﻳﺴﺘﻌﻤﻞ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد رﻗﻢ ١، اﻟﻮارد ﰲ اﳌﻠﺤﻖ ١، ﻟﺘﻐﻄﻴﺔ ﺟﻤﻴﻊ ﻋﻤﻠﻴﺎت ﻧﻘﻞ اﳌﻮاد \n٥–٤–١ \nاﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻣﺎدام اﻻﺗﻔﺎق ﺳﺎرﻳﺎً.\nﺑﻨﺎءً ﻋﲆ اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد رﻗﻢ ٢، اﻟﻮارد ﰲ اﳌﻠﺤﻖ ٢، ﻳﻌﻘﺪ اﳌﺪﻳﺮ اﻟﻌﺎم اﺗﻔﺎﻗﺎت ﻣﻊ \n٥–٤–٢ \nﻫﻴﺌﺎت ﻣﻦ ﺧﺎرج ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ. وﺳﺘﺸﻤﻞ ﻫﺬه اﻻﺗﻔﺎﻗﺎت ﺟﻤﻴﻊ ﻋﻤﻠﻴﺎت ﻧﻘﻞ اﳌﻮاد اﻟﺨﺎﺻﺔ \nﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ إﱃ اﻟﺠﻬﺎت اﳌﺘﻠﻘﻴﺔ ﻣﺎداﻣﺖ ﻫﺬه اﻻﺗﻔﺎﻗﺎت ﺳﺎرﻳﺔ.\n٦– ﻧﻈﺎم ﺗﺒﺎدل ﻓﻮاﺋﺪ اﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\nاﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ\n٦–٠ \nﻳﻨﺒﻐﻲ ﻟﻠﺪول اﻷﻋﻀﺎء، ﰲ ﻋﻤﻠﻬﺎ ﻣﻊ أﻣﺎﻧﺔ اﳌﻨﻈﻤﺔ، أن ﺗﺴﻬﻢ ﰲ ﻗﻴﺎم ﻧﻈﺎم ﻟﺘﺒﺎدل اﻟﻔﻮاﺋﺪ ﻓﻴام \n٦–٠–١ \nﻳﺘﻌﻠﻖ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ وأن ﺗﺪﻋﻮ اﳌﺆﺳ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States that Standard Material Transfer Agreement 1 covers transfers within WHO's network and SMTA 2 covers transfers outside it. It then opens section 6 on benefit sharing, setting out its general provisions, such as surveillance, risk assessment and capacity building.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "ﺗﻨﺴﻴﻖ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﻟﻠﺘﺄﻫﺐ واﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "pageStart": 22,
      "pageEnd": 24,
      "target": "../sections/sec-011-ﺗﻨﺴﻴﻖ-ﻣﻨﻈﻤﺔ-اﻟﺼﺤﺔ-اﻟﻌﺎﳌﻴﺔ-ﻟﻠﺘﺄﻫﺐ-واﻟﺘﺼﺪي-ﻟﻸﻧﻔﻠﻮﻧ.md",
      "narrative": null,
      "content": "٦–١ \nﺳﺘﻨﺴﻖ اﳌﻨﻈﻤﺔ أﻧﺸﻄﺔ اﻟﺘﺄﻫﺐ واﻟﺘﺼﺪي ﻟﺠﻮاﺋﺢ اﻷﻧﻔﻠﻮﻧﺰا ﻃﺒﻘﺎً ﻟﻸﺣﻜﺎم اﳌﻨﻄﺒﻘﺔ اﻟﻮاردة ﰲ اﻟﻠﻮاﺋﺢ اﻟﺼﺤﻴﺔ \nاﻟﺪوﻟﻴﺔ )٥٠٠٢( وﰲ ﻫﺬا اﻹﻃﺎر. وﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺎﻟﻔﻮاﺋﺪ اﳌﻮﺟﺰة ﰲ ﻫﺬا اﻹﻃﺎر ﻳﻨﺒﻐﻲ ﻟﻠﻤﻨﻈﻤﺔ أن ﺗﻮﱄ اﻫﺘامﻣﺎً ﺧﺎﺻﺎً \nﻟﻠﺴﻴﺎﺳﺎت واﳌامرﺳﺎت اﻟﺘﻲ ﺗﻌﺰز ﺗﺨﺼﻴﺺ اﳌﻮارد اﻟﻄﺒﻴﺔ اﻟﺸﺤﻴﺤﺔ ﺑﻄﺮﻳﻘﺔ ﻋﺎدﻟﺔ وﻣﻨﺼﻔﺔ وﺷﻔﺎﻓﺔ )مبﺎ ﻓﻴﻬﺎ ﻋﲆ \nﺳﺒﻴﻞ اﳌﺜﺎل ﻻ اﻟﺤﴫ اﻟﻠﻘﺎﺣﺎت وﻣﻀﺎدات اﻟﻔريوﺳﺎت وﻣﻮاد اﻟﺘﺸﺨﻴﺺ( ﻃﻮال اﻟﺠﻮاﺋﺢ، وذﻟﻚ ﺑﻨﺎءً ﻋﲆ اﳌﺨﺎﻃﺮ \nواﺣﺘﻴﺎﺟﺎت اﻟﺼﺤﺔ اﻟﻌﻤﻮﻣﻴﺔ، مبﺎ ﰲ ذﻟﻚ ﻣﻦ دراﺳﺎت ﻋﻦ وﺑﺎﺋﻴﺎت اﻟﺠﺎﺋﺤﺔ. وﺧﻼل اﻟﻔﱰات اﻟﺘﻲ ﺗﻨﻘﴤ ﺑني ﺟﺎﺋﺤﺔ \nوأﺧﺮى ﺗﻌﻤﻞ اﳌﻨﻈﻤﺔ ﻣﻊ اﻟﺪول اﻷﻋﻀﺎء وأﺻﺤﺎب اﳌﺼﻠﺤﺔ اﳌﻌﻨﻴني ﻋﲆ اﻟﺘﺤﻀري ﻷداء اﻟﺪور اﳌﺬﻛﻮر أﻋﻼه.\nﺗﻘﺪﻳﺮ ا",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes WHO coordination of pandemic preparedness and response under the International Health Regulations (2005), with fair allocation of scarce resources. It also covers pandemic risk assessment and the supply of candidate vaccine viruses, diagnostic reagents and test kits. Laboratory and surveillance capacity building in developing countries is also addressed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "ﺑﻨﺎء اﻟﻘﺪرات اﻟﺘﻨﻈﻴﻤﻴﺔ",
      "pageStart": 24,
      "pageEnd": 26,
      "target": "../sections/sec-012-ﺑﻨﺎء-اﻟﻘﺪرات-اﻟﺘﻨﻈﻴﻤﻴﺔ.md",
      "narrative": null,
      "content": "٦–٧ \nﻳﻨﺒﻐﻲ ﻟﻠﺪول اﻷﻋﻀﺎء ذات اﻟﻘﺪرة اﻟﺘﻨﻈﻴﻤﻴﺔ اﳌﺘﻄﻮرة أن ﺗﺤﺴﻦ وﺗﻌﺰز، ﻋﻨﺪ اﻟﻄﻠﺐ، \n٦–٧–١ \nاﻟﻌﻤﻞ اﻟﺬي ﺗﻀﻄﻠﻊ ﺑﻪ اﻟﺪول اﻷﻋﻀﺎء ﻣﻊ اﳌﻨﻈﻤﺔ، وﻻﺳﻴام اﻟﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ، ﻟﺘﻌﺰﻳﺰ \nﻗﺪرة اﻟﺴﻠﻄﺎت اﻟﺘﻨﻈﻴﻤﻴﺔ ﻋﲆ اﺗﺨﺎذ اﻟﺘﺪاﺑري اﻟﻼزﻣﺔ ﻟﻠﻤﻮاﻓﻘﺔ اﻟﴪﻳﻌﺔ ﻋﲆ ﻟﻘﺎﺣﺎت \nاﻷﻧﻔﻠﻮﻧﺰا ووﺳﺎﺋﻞ ﺗﺸﺨﻴﺺ اﻷﻧﻔﻠﻮﻧﺰا واﳌﺴﺘﺤﴬات اﻟﺼﻴﺪﻻﻧﻴﺔ اﳌﻀﺎدة ﻟﻬﺎ اﳌﺄﻣﻮﻧﺔ \nواﻟﻨﺎﺟﻌﺔ، مبﺎ ﰲ ذﻟﻚ ﺗﻠﻚ اﻟﺘﻲ ﺗُﺴﺘﺤﺪث ﻣﻦ اﺳﺘﻌامل اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ \nﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ، وﻻﺳﻴام ﻣﺎ ﻳﺘﻢ اﺷﺘﻘﺎﻗﻪ ﻣﻦ اﻷمنﺎط اﻟﻔﺮﻋﻴﺔ اﻟﺠﺪﻳﺪة ﻣﻦ \nﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا.\nﻳﻨﺒﻐﻲ أن ﺗﺘﻴﺢ اﻟﺪول اﻷﻋﻀﺎء ﻋﲆ اﳌﻸ اﳌﻌﻠﻮﻣﺎت ﻋﻦ إﺧﻄﺎرات اﳌﻮاﻓﻘﺔ اﻟﺘﻨﻈﻴﻤﻴﺔ اﻟﺼﺤﻴﺔ \n٦–٧–٢ \n وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Covers regulatory capacity building for rapid approval of influenza products, national antiviral stockpiles and the WHO stockpile of PIP vaccines, including deployment plans and use in affected countries before a pandemic.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "٦–٠١ إﺗﺎﺣﺔ اﻟﻠﻘﺎﺣﺎت ﰲ اﻟﻔﱰة اﻟﻔﺎﺻﻠﺔ ﺑني أي ﺟﺎﺋﺤﺘني ﰲ اﻟﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ",
      "pageStart": 26,
      "pageEnd": 29,
      "target": "../sections/sec-013-٦٠١-إﺗﺎﺣﺔ-اﻟﻠﻘﺎﺣﺎت-ﰲ-اﻟﻔﱰة-اﻟﻔﺎﺻﻠﺔ-ﺑني-أي-ﺟﺎﺋﺤﺘن.md",
      "narrative": null,
      "content": "ﺑﴫف اﻟﻨﻈﺮ ﻋﻦ اﻟﺘﺪاﺑري اﻟﺮاﻣﻴﺔ إﱃ دﻋﻢ ﻣﺨﺰون اﳌﻨﻈﻤﺔ اﻻﺣﺘﻴﺎﻃﻲ ﻣﻦ ﻟﻘﺎﺣﺎت اﻟﺘﺄﻫﺐ \n٦–٠١–١ \nﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ اﳌﺒﻴﻨﺔ ﰲ اﻟﻔﺮع ٦–٩ أﻋﻼه ﻳﻨﺒﻐﻲ ﻟﻠﺪول اﻷﻋﻀﺎء:\nأن ﺗﺤﺚ ﻣﻨﺘﺠﻲ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻋﲆ أن ﻳﻘﺘﻄﻌﻮا ﺟﺰءاً ﻣﻦ ﻛﻞ دورة ﻹﻧﺘﺎج ﻟﻘﺎﺣﺎت \n)١( \n وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ وﻳﺨﺼﺼﻮه H5N1 اﻟﻔريوس\nﻟﻠﺨﺰن و/ أو ﻟﻼﺳﺘﻌامل ﻣﻦ ﻗِﺒَﻞ اﻟﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ؛\nأن ﺗﻮاﺻﻞ اﻟﻌﻤﻞ ﻣﻊ ﺑﻌﻀﻬﺎ وﻣﻊ اﳌﺪﻳﺮ اﻟﻌﺎم وﻣﻨﺘﺠﻲ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻋﲆ ﺗﺄﻣني ﻛﻤﻴﺎت \n)٢( \n وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى H5N1 ﻛﺎﻓﻴﺔ ﻣﻦ ﻟﻘﺎﺣﺎت ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ\nاﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ ﺑﴩﻳﺔ، وإﺗﺎﺣﺔ ﻫﺬه اﻟﻠﻘﺎﺣﺎت ﻟﻠﺒﻠﺪان اﻟﻨﺎﻣﻴﺔ ﻋﻨﺪ إﺗﺎﺣﺘﻬﺎ ﻟﻠﺒﻠﺪان \nاﳌﺘﻘﺪﻣﺔ، وذﻟﻚ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes measures to improve access to pandemic influenza vaccines in developing countries between and during pandemics, including reserving part of production, tiered pricing based on country income and technology transfer. It sets out the annual partnership contribution from manufacturers, benchmarked at half the estimated US$56.6 million running cost of the WHO network in 2010.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "٧– ﺗﴫﻳﻒ اﻟﺸﺆون، واﻻﺳﺘﻌﺮاض",
      "pageStart": 29,
      "pageEnd": 31,
      "target": "../sections/sec-014-٧-ﺗﴫﻳﻒ-اﻟﺸﺆون-واﻻﺳﺘﻌﺮاض.md",
      "narrative": null,
      "content": "اﻷﺣﻜﺎم اﻟﻌﺎﻣﺔ\n٧–١ \nﺗﺘﻮﱃ ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ اﻹﴍاف ﻋﲆ ﺗﻨﻔﻴﺬ ﻫﺬا اﻹﻃﺎر مبﺸﻮرة ﻣﻦ اﳌﺪﻳﺮ اﻟﻌﺎم.\n٧–١–١ \nﺗﻨﺸﺄ مبﻮﺟﺐ ﻫﺬه اﻟﻮﺛﻴﻘﺔ آﻟﻴﺔ ﻟﻠﻤﺮاﻗﺒﺔ ﺗﻀﻢ ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ واﳌﺪﻳﺮ اﻟﻌﺎم \n٧–١–٢ \nو»اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري« اﳌﺴﺘﻘﻞ اﳌﻨﺸﺄ ﰲ إﻃﺎر اﻟﺒﻴﺎن اﳌﺒﺪيئ اﻟﺼﺎدر ﰲ ﺗﴩﻳﻦ اﻟﺜﺎين/ ﻧﻮﻓﻤﱪ \n٧٠٠٢ واﳌﺆﻟﻒ ﻣﻦ ﺧﱪاء دوﻟﻴني ﻳﺨﺪﻣﻮن اﳌﻨﻈﻤﺔ ﺑﺸﻜﻞ ﺣﴫي. وﺗﺮد أدﻧﺎه وﻇﺎﺋﻒ ﻛﻞ ﻣﻦ \nﻫﺆﻻء:\nﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﻫﻲ اﻟﺘﻲ ﺗﺘﻮﱃ ﺗﻨﻔﻴﺬ ﻫﺬا اﻹﻃﺎر وذﻟﻚ وﻓﻘﺎً ﳌﻬﻤﺘﻬﺎ \n)١( \nاﻟﺪﺳﺘﻮرﻳﺔ اﳌﺘﻤﺜﻠﺔ ﰲ اﻟﻌﻤﻞ »ﻛﺴﻠﻄﺔ ﺗﻮﺟﻴﻪ وﺗﻨﺴﻴﻖ« ﺣﺴﺐ اﳌﺎدة ٢)أ( ﻣﻦ \nدﺳﺘﻮر اﳌﻨﻈﻤﺔ.\nاﳌﺪﻳﺮ اﻟﻌﺎم ﻫﻮ اﻟﺬي ﻳﺘﻮﱃ، وﻓﻘﺎً ﻟﻸدوار واﳌﺴﺆوﻟﻴﺎت اﳌﻨﻮﻃﺔ ﺑﻪ وﺧﺎﺻﺔ ﻓﻴام ﻳﺘﻌﻠﻖ \n)٢( \nﺑﺎﻻﺗﺼﺎل ﺑﺎﳌﺆﺳﺴﺎت اﳌﺘ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out governance of the framework, with oversight by the World Health Assembly and an independent Advisory Group of international experts. It also describes how the Director-General reviews breaches of terms of reference or transfer agreements and may suspend or revoke a laboratory's WHO designation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "رﺻﺪ واﺳﺘﻌﺮاض اﻹﻃﺎر",
      "pageStart": 31,
      "pageEnd": 33,
      "target": "../sections/sec-015-رﺻﺪ-واﺳﺘﻌﺮاض-اﻹﻃﺎر.md",
      "narrative": null,
      "content": "٧–٤ \nﻳﻘﺪم اﳌﺪﻳﺮ اﻟﻌﺎم، ﺑﺎﻟﺘﺸﺎور ﻣﻊ اﻟﺪول اﻷﻋﻀﺎء واﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري، إﱃ ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ ﻋﻦ \n٧–٤–١ \nﻃﺮﻳﻖ اﳌﺠﻠﺲ اﻟﺘﻨﻔﻴﺬي ﺗﻘﺮﻳﺮاً ﻛﻞ ﻋﺎﻣني ﻋﻦ اﻟﺤﺎﻟﺔ واﻟﺘﻘﺪم اﳌﺤﺮز ﺑﺸﺄن ﻣﺎ ﻳﲇ:\nﻗﺪرات اﳌﺨﺘﱪات واﻟﱰﺻﺪ )اﻟﻔﺮع ٦–٦ ﻣﻦ ﻫﺬا اﻹﻃﺎر(\n)١( \nﻗﺪرات إﻧﺘﺎج ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا ﰲ اﻟﻌﺎمل )اﻧﻈﺮ اﻟﻔﺮﻋني ٦–٣١–١ و٦–٣١–٢ ﻣﻦ ﻫﺬا \n)٢( \nاﻹﻃﺎر(\nﺣﺎﻟﺔ اﻻﺗﻔﺎﻗﺎت اﳌﻌﻘﻮدة ﻣﻊ دواﺋﺮ اﻟﺼﻨﺎﻋﺔ، وﻻﺳﻴام اﳌﻌﻠﻮﻣﺎت اﳌﺘﻮﻓﺮة ﻋﻦ اﻟﻠﻘﺎﺣﺎت \n)٣( \nوﻣﻀﺎدات اﻟﻔريوﺳﺎت وﺳﺎﺋﺮ اﳌﻮاد اﻟﻼزﻣﺔ ﻟﻠﺘﺼﺪي ﻟﻠﺠﻮاﺋﺢ )اﻧﻈﺮ اﻟﻔﺮﻋني ٦–٤١–٣ \nو٦–٤١–٤(\nاﻟﺘﻘﺮﻳﺮ اﳌﺎﱄ ﻋﻦ اﺳﺘﻌامل اﺷﱰاﻛﺎت اﻟﴩﻛﺎء )اﻟﻔﺮع ٦–٤١–٥(\n)٤( \nاﻟﺨﱪة اﳌﻜﺘﺴﺒﺔ ﻣﻦ اﺳﺘﻌامل اﻟﺘﻌﺮﻳﻒ اﻟﻮارد ﰲ اﻟﻔﺮع ٤–١ ﻟﻠﻤﻮاد اﻟﺒﻴﻮﻟ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Requires the Director-General to report to the World Health Assembly every two years on laboratory capacity, vaccine production capacity, benefit sharing and contributions, and schedules a review of the framework by 2016.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌـﻼﺣــﻖ",
      "pageStart": 33,
      "pageEnd": 35,
      "target": "../sections/sec-016-اﳌـﻼﺣــﻖ.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌﻠﺤﻖ ١",
      "pageStart": 35,
      "pageEnd": 37,
      "target": "../sections/sec-017-اﳌﻠﺤﻖ-١.md",
      "narrative": null,
      "content": "اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد رﻗﻢ ١\nداﺧﻞ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا\nواﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ\nﺗﻌﺰﻳﺰاً ﻟﻺﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺑﺘﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ \nاﻷﺧﺮى )»اﻹﻃﺎر«( أﻋﺪ ﻫﺬا اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد )»اﻻﺗﻔﺎق« أو »اﻻﺗﻔﺎق رﻗﻢ ١«(.\nاﳌﺎدة ١– اﻟﻄﺮﻓﺎن ﰲ ﻫﺬا اﻻﺗﻔﺎق\n ،اﻟﻄﺮﻓﺎن ﰲ ﻫﺬا اﻻﺗﻔﺎق رﻗﻢ ١ ﻫام ﺣﴫاً ﻣﻦ ﻣﺨﺘﱪات اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﻲ ﻋﻴﻨﺘﻬﺎ اﳌﻨﻈﻤﺔ أو اﻋﱰﻓﺖ ﺑﻬﺎ\n١–١ \nوﻗﺒﻠﺖ ﻫﺬه اﳌﺨﺘﱪات اﻟﻌﻤﻞ ﺑﺎﻻﺧﺘﺼﺎﺻﺎت اﻟﺘﻲ واﻓﻘﺖ ﻋﻠﻴﻬﺎ اﳌﻨﻈﻤﺔ. وﻷﻏﺮاض ﻫﺬا اﻻﺗﻔﺎق:\nاﳌﻮرﱢد ﻫﻮ اﳌﺨﺘﱪ اﻟﺬي ﻳﺮﺳﻞ اﳌﻮاد ﺣﺴﺐ ﺗﻌﺮﻳﻔﻪ ﻫﻨﺎ\n \n)اﺳﻢ اﳌﻮرﱢد وﻋﻨﻮاﻧﻪ أو اﺳﻢ اﳌﺆﺳﺴﺔ اﳌﻮرﱢدة وﻋﻨﻮاﻧﻬﺎ، وﺻﻔﺔ اﳌﺨﺘﱪ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 1, Standard Material Transfer Agreement 1 for transfers within WHO's global influenza surveillance network, setting out the parties, the materials covered and obligations such as involving and acknowledging scientists from originating countries.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌﺎدة ٦– ﺣﻘﻮق اﳌﻠﻜﻴﺔ اﻟﻔﻜﺮﻳﺔ",
      "pageStart": 37,
      "pageEnd": 39,
      "target": "../sections/sec-018-اﳌﺎدة-٦-ﺣﻘﻮق-اﳌﻠﻜﻴﺔ-اﻟﻔﻜﺮﻳﺔ.md",
      "narrative": null,
      "content": ".ﻻ ﻳﺤﻖ ﻟﻠﻤﻮرد واﳌﺘﻠﻘﻲ اﻟﺘامس أي ﺣﻘﻮق ﻣﻠﻜﻴﺔ ﻓﻜﺮﻳﺔ ﺑﺨﺼﻮص اﳌﻮاد\n٦–١ \nﻳﻘﺮ اﳌﻮرد واﳌﺘﻠﻘﻲ ﺑﺄن ﻫﺬا اﻻﺗﻔﺎق رﻗﻢ ١ ﻻ ﻣﺴﺎس ﻓﻴﻪ ﺑﺄي ﺣﻘﻮق ﻣﻠﻜﻴﺔ ﻓﻜﺮﻳﺔ ﺑﺨﺼﻮص اﳌﻮاد اﻟﺘﻲ \n٦–٢ \nﺗﻢ اﻟﺤﺼﻮل ﻋﻠﻴﻬﺎ ﻗﺒﻞ ﺗﺎرﻳﺦ اﻋﺘامد اﻹﻃﺎر ﰲ ﺟﻤﻌﻴﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ.\nﻳﺠﻮز أن ﻳﻜﻮن اﳌﻮرد اﳌﻨﺼﻮص ﻋﻠﻴﻪ ﰲ ﻫﺬا اﻻﺗﻔﺎق رﻗﻢ ١ ﻗﺪ اﺳﺘﻌﻤﻞ ﺗﻜﻨﻮﻟﻮﺟﻴﺎ ﻣﺤﻤﻴﺔ ﺑﺤﻘﻮق \n٦–٣ \nاﳌﻠﻜﻴﺔ اﻟﻔﻜﺮﻳﺔ ﻹﻧﺘﺎج اﳌﻮاد و/ أو ﺗﺤﻮﻳﺮﻫﺎ. ﻓﻴﻘﺮ ﻣﺘﻠﻘﻲ ﻫﺬه اﳌﻮاد ﺑﺎﺣﱰام ﻫﺬه اﻟﺤﻘﻮق.\nاﳌﺎدة ٧– ﻓﺾ اﻟﻨﺰاﻋﺎت\n ﻋﻨﺪﻣﺎ ﻳﻨﺸﺄ ﻧﺰاع ﰲ إﻃﺎر ﻫﺬا اﻻﺗﻔﺎق رﻗﻢ ١، ﻳﻠﺘﻤﺲ اﻟﻄﺮﻓﺎن ﰲ اﳌﻘﺎم اﻷول ﺗﺴﻮﻳﺘﻪ ﺑﺎﻟﺘﻔﺎوض أو\n٧–١ \nﺑﺄي وﺳﻴﻠﺔ ودﻳﺔ أﺧﺮى ﻳﻔﻀﻼﻧﻬﺎ. واﻹﺧﻔﺎق ﰲ اﻟﺘﻮﺻﻞ إﱃ اﺗﻔﺎق ﻻ ﻳﺠﻌﻞ ﻃﺮﰲ اﻟﻨﺰاع ﰲ ﺣﻞ ﻣﻦ \nﻣﺴﺆوﻟﻴﺘﻬام ﻋ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Articles of SMTA 1 stating that neither party may seek intellectual property rights on the materials, with terms on prior rights, dispute settlement, suspension or withdrawal and acceptance without a printed signature.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-019",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌﻠﺤﻖ ٢",
      "pageStart": 39,
      "pageEnd": 41,
      "target": "../sections/sec-019-اﳌﻠﺤﻖ-٢.md",
      "narrative": null,
      "content": "اﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد ٢\nاﻻﺗﻔﺎق اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد رﻗﻢ ٢ ﺧﺎرج اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ \nﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ\nاﳌﺎدة ١– اﻟﻄﺮﻓﺎن ﰲ ﻫﺬا اﻻﺗﻔﺎق\nﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ واﳌﺘﻠﻘﻲ.١\nاﳌﺎدة ٢– ﻣﻮﺿﻮع ﻫﺬا اﻻﺗﻔﺎق\n ﺗﺨﻀﻊ ﻷﺣﻜﺎم ﻫﺬا اﻻﺗﻔﺎق اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ، ﺣﺴﺐ ﺗﻌﺮﻳﻔﻬﺎ ﰲ اﻟﻔﺮع ٤–١\nﻣﻦ اﻹﻃﺎر )وﺗﺪﻋﻰ ﻓﻴام ﺑﻌﺪ »اﳌﻮاد«(، اﳌﻨﻘﻮﻟﺔ إﱃ اﳌﺘﻠﻘﻲ.\nاﳌﺎدة ٢ ﻣﻜﺮر– اﻟﺘﻌﺎرﻳﻒ\n ﺣﺴﺒام وردت ﰲ اﻟﻔﺮع ٤ ﻣﻦ اﻹﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻟﺘﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا\n)أ( \nواﻟﺘﻮﺻﻞ إﱃ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى.\nاﳌﺼﻄﻠﺤﺎت اﻷﺧﺮى اﻟﺘﻲ ﻳﺘﻔﻖ ﻋﻠﻴﻬﺎ اﻟﻄﺮﻓﺎن.\n)ب( \nاﳌﺎدة ٣– اﻟﺘﺰاﻣﺎت اﳌﻮرد\n.ﻳﺘﻔﻖ ﻋﻠﻴ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 2, Standard Material Transfer Agreement 2 between WHO and recipients outside its network, setting out the parties, materials and the recipient's commitments, including onward sharing only with other SMTA holders.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-020",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌﺎدة ٥– ﻓﺾ اﻟﻨﺰاﻋﺎت",
      "pageStart": 41,
      "pageEnd": 43,
      "target": "../sections/sec-020-اﳌﺎدة-٥-ﻓﺾ-اﻟﻨﺰاﻋﺎت.md",
      "narrative": null,
      "content": "ﻋﻨﺪﻣﺎ ﻳﺘﻌﺬر ﺣﻞ أي ﻧﺰاع ﺑﺎﳌﻔﺎوﺿﺎت أو ﺑﺄي وﺳﺎﺋﻞ أﺧﺮى ﻏري ﻣﻠﺰﻣﺔ ﻳﺮﺗﻀﻴﻬﺎ اﻟﻄﺮﻓﺎن، ﻳﻌﺮض اﻟﻨﺰاع ﻋﲆ\nاﻟﺘﺤﻜﻴﻢ ﺑﺎﻟﴩوط اﻟﺘﻲ ﻳﺮﺗﻀﻴﻬﺎ اﻟﻄﺮﻓﺎن وﺗﺼﺒﺢ ﻗﺮارات اﻟﺘﺤﻜﻴﻢ ﻣﻠﺰﻣﺔ.\nاﳌﺎدة ٦– اﳌﺴﺆوﻟﻴﺔ واﻟﺘﻌﻮﻳﺾ\n.ﻳﺘﻔﻖ ﻋﻠﻴﻬام اﻟﻄﺮﻓﺎن\nاﳌﺎدة ٧– اﻻﻣﺘﻴﺎزات واﻟﺤﺼﺎﻧﺎت\n ﻻ ﻳﻮﺟﺪ ﰲ ﻫﺬه اﻟﴩوط وﻻ ﰲ ﻣﺎ ﻳﺘﻌﻠﻖ ﺑﻬﺎ ﻣﺎ ﻳﻠﺰم اﳌﻨﻈﻤﺔ ﺑﺎﻟﺨﻀﻮع ﻷي ﺗﴩﻳﻊ وﻃﻨﻲ أو وﻻﻳﺔ ﻗﺎﻧﻮﻧﻴﺔ\nوﻃﻨﻴﺔ، وﻻ ﻣﺎ ﻳﻌﺘﱪ ﺗﻨﺎزﻻً ﻋﻦ أي ﻣﻦ اﻣﺘﻴﺎزاﺗﻬﺎ وﺣﺼﺎﻧﺎﺗﻬﺎ اﳌﻨﺼﻮص ﻋﻠﻴﻬﺎ ﰲ »اﺗﻔﺎﻗﻴﺔ اﻣﺘﻴﺎزات اﻟﻮﻛﺎﻻت \nاﳌﺘﺨﺼﺼﺔ وﺣﺼﺎﻧﺎﺗﻬﺎ« اﻟﺘﻲ اﻋﺘﻤﺪﻫﺎ اﻷﻣني اﻟﻌﺎم ﻟﻸﻣﻢ اﳌﺘﺤﺪة ﰲ ١٢ ﺗﴩﻳﻦ اﻟﺜﺎين/ ﻧﻮﻓﻤﱪ ٧٤٩١ أو اﻻﻣﺘﻴﺎزات \nواﻟﺤﺼﺎﻧﺎت اﳌﻤﻨﻮﺣﺔ ﻟﻬﺎ مبﻮﺟﺐ أي ﻗﺎﻧﻮن أو اﺗﻔﺎﻗﻴﺔ أو اﺗﻔﺎق ﻋﲆ اﻟﺼﻌﻴﺪ اﻟﻮﻃﻨﻲ أو اﻟﺪ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Further articles of SMTA 2 on dispute settlement by binding arbitration, WHO's privileges and immunities, and signature, with several terms left for the parties to agree.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-021",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌﻠﺤﻖ ٣",
      "pageStart": 43,
      "pageEnd": 45,
      "target": "../sections/sec-021-اﳌﻠﺤﻖ-٣.md",
      "narrative": null,
      "content": "اﺧﺘﺼﺎﺻﺎت\nاﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري\n)أﻗﺮﻫﺎ اﻻﺟﺘامع اﻟﺤﻜﻮﻣﻲ اﻟﺪوﱄ ﰲ دورﺗﻪ اﳌﺴﺘﺄﻧﻔﺔ اﳌﻌﻘﻮدة ﰲ ﻛﺎﻧﻮن اﻷول/ دﻳﺴﻤﱪ ٨٠٠٢ ﺑﺎﻟﺼﻴﻐﺔ اﻟﺘﻲ \nﻋﺪﻟﻬﺎ ﺑﻬﺎ ﰲ ﻧﻴﺴﺎن/ أﺑﺮﻳﻞ ١١٠٢ اﻟﻔﺮﻳﻖ اﻟﻌﺎﻣﻞ اﳌﻔﺘﻮح اﻟﻌﻀﻮﻳﺔ ﻟﻠﺪول اﻷﻋﻀﺎء واﳌﻌﻨﻲ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا \nاﻟﺠﺎﺋﺤﺔ: ﺗﺒﺎدل ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﻮﺻﻞ ﻋﲆ اﻟﻠﻘﺎﺣﺎت واﻟﻔﻮاﺋﺪ اﻷﺧﺮى(.\n١– اﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ ووﻻﻳﺔ اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري\n دﻋﺎ اﻟﺒﻴﺎن اﳌﺆﻗﺖ اﻟﺬي اﻋﺘﻤﺪﺗﻪ اﻟﺪول اﻷﻋﻀﺎء ﰲ اﳌﻨﻈﻤﺔ اﻟﺘﻲ ﺷﺎرﻛﺖ ﰲ دورة اﻻﺟﺘامع\n١–١ \nاﻟﺤﻜﻮﻣﻲ اﻟﺪوﱄ اﳌﻌﻨﻲ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ، اﳌﻌﻘﻮدة ﰲ اﻟﻔﱰة ﻣﻦ ٠٢ إﱃ ٣٢ ﺗﴩﻳﻦ \nاﻟﺜﺎين/ ﻧﻮﻓﻤﱪ ٧٠٠٢، إﱃ اﺗﺨﺎذ إﺟﺮاءات ﻋﺎﺟﻠﺔ ﻣﻦ أﺟﻞ إﻗﺎﻣﺔ آﻟﻴﺎت دوﻟﻴﺔ ﻋﺎدﻟﺔ وﺷﻔﺎﻓﺔ \nوﻣﻨﺼﻔﺔ ﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺘﺒﺎدل ا",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 3, the terms of reference of the PIP Advisory Group, setting out its functions of monitoring the framework and advising on topics such as stockpiles, surveillance, the traceability mechanism and use of contributions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-022",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "٣– ﺗﻌﻴني اﻷﻋﻀﺎء",
      "pageStart": 45,
      "pageEnd": 48,
      "target": "../sections/sec-022-٣-ﺗﻌﻴني-اﻷﻋﻀﺎء.md",
      "narrative": null,
      "content": "ﺳﻴﺘﺄﻟﻒ اﻟﻔﺮﻳﻖ اﻻﺳﺘﺸﺎري ﻣﻦ ٨١ ﻋﻀﻮاً ﻳﻨﺘﻤﻮن إﱃ ﺛﻼث دول أﻋﻀﺎء ﻣﻦ ﻛﻞ إﻗﻠﻴﻢ ﻣﻦ أﻗﺎﻟﻴﻢ اﳌﻨﻈﻤﺔ\n٣–١ \nوﻳﺘﺤﻠﻮن مبﺠﻤﻮﻋﺔ ﻣﺘﻨﻮﻋﺔ ﻣﻦ اﳌﻬﺎرات اﳌﻌﱰف ﺑﻬﺎ ﻋﲆ اﻟﺼﻌﻴﺪ اﻟﺪوﱄ ﰲ ﻣﺠﺎل رﺳﻢ اﻟﺴﻴﺎﺳﺎت وﻣﻦ \nﺧﱪاء اﻟﺼﺤﺔ اﻟﻌﻤﻮﻣﻴﺔ واﻟﺨﱪاء اﻟﺘﻘﻨﻴني ﰲ ﻣﺠﺎل اﻷﻧﻔﻠﻮﻧﺰا. وﻳﻌﻤﻞ اﻷﻋﻀﺎء، ﰲ ﻣامرﺳﺘﻬﻢ ﳌﻬﺎﻣﻬﻢ، \nﺑﻮﺻﻔﻬﻢ ﺧﱪاء دوﻟﻴني ﻳﺨﺪﻣﻮن ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ وﺣﺪﻫﺎ.\nﻳﻌﻤﻞ ﻛﻞ ﻋﻀﻮ ﻟﺜﻼث ﺳﻨﻮات. وﺗﺴﺘﻐﺮق ﻣﺪة ﺗﻌﻴني ﻛﻞ ﻋﻀﻮ ﺛﻼث ﺳﻨﻮات ﻣﻊ ﺗﺠﺪﻳﺪ ﺗﻌﻴني ﺛُﻠﺚ \n٣–٢ \nاﻷﻋﻀﺎء ﰲ ﻛﻞ ﻋﺎم؛ وﻳﺠﺐ ﻋﻨﺪ ﺗﺒﺪﻳﻞ اﻷﻋﻀﺎء اﻟﺤﻔﺎظ ﻋﲆ اﻟﺘﻤﺜﻴﻞ اﳌﻨﺼﻒ ﻷﻗﺎﻟﻴﻢ اﳌﻨﻈﻤﺔ اﻟﺴﺘﺔ \nواﻟﺒﻠﺪان اﳌﻮﺑﻮءة؛ وﺟﻤﻴﻊ اﻷﻋﻀﺎء ﻣﺆﻫﻠﻮن ﻟﻘﻀﺎء ﻣﺪيت ﺗﻌﻴني ﻓﻘﻂ. وﰲ ﺣﺎﻟﺔ اﺳﺘﻘﺎﻟﺔ أي ﻋﻀﻮ أو \nﻋﺠﺰه ﻋﻦ اﻟﻌﻤﻞ ﻷي ﺳﺒﺐ ﻣﻦ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how the 18-member Advisory Group is formed from three Member States per WHO region and how it operates, including meetings, reporting and conflicts of interest. A further section lists commitments on sharing genetic sequence data and acknowledging laboratories that supply PIP materials.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-023",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌﻠﺤﻖ ٥",
      "pageStart": 48,
      "pageEnd": 50,
      "target": "../sections/sec-023-اﳌﻠﺤﻖ-٥.md",
      "narrative": null,
      "content": "اﳌﺮاﻛﺰ اﳌﺘﻌﺎوﻧﺔ ﻣﻊ ﻣﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا\nاﻻﺧﺘﺼﺎﺻﺎت اﳌﺘﻌﻠﻘﺔ ﺑﺎﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ\nاﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\nاﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ\n ﺗُﻌﺪ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ آﻟﻴﺔ ﻋﺎﳌﻴﺔ ﻟﻠﺘﺤﺬﻳﺮ إﱃ ﻇﻬﻮر\nﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ذات اﻟﺴامت اﻟﻼﻓﺘﺔ، مبﺎ ﰲ ذﻟﻚ اﻟﻔريوﺳﺎت اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ. وﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺎﻷﻧﺸﻄﺔ \nذات اﻟﺼﻠﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺗﻀﻢ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ أرﺑﻊ ﻓﺌﺎت ﻣﺘﻜﺎﻣﻠﺔ ﻣﻦ اﳌﺆﺳﺴﺎت واﳌﺨﺘﱪات، أﻻ وﻫﻲ: \nاﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا، واﳌﺮاﻛﺰ اﳌﺘﻌﺎوﻧﺔ ﻣﻊ اﳌﻨﻈﻤﺔ، واﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ \n، واﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ. واﻟﱪﻧﺎﻣﺞ اﻟﻌﺎﳌﻲ ﺑﺸ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Annex 5, terms of reference for WHO collaborating centres for influenza when handling PIP materials, describing the global surveillance network and their duties on sharing materials and sequence data.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-024",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "pageStart": 50,
      "pageEnd": 55,
      "target": "../sections/sec-024-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ.md",
      "narrative": null,
      "content": ":اﳌﺮاﻛﺰ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﳌﺘﻌﺎوﻧﺔ ﻣﻊ اﳌﻨﻈﻤﺔ ﻫﻲ ﻣﺮاﻛﺰ اﻣﺘﻴﺎز ﺗﻌﻴﻨﻬﺎ اﳌﻨﻈﻤﺔ وﺗﻔﻲ مبﺎ ﻳﲇ\nأﻟﻒ: اﻟﴩوط اﻟﻌﺎﻣﺔ واﻷﻧﺸﻄﺔ\nاﻟﻌﻤﻞ ﰲ إﻃﺎر اﻟﺘﻨﺴﻴﻖ اﻟﺬي ﻳﺘﻮﻻه ﺑﺮﻧﺎﻣﺞ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻲ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا، وﺗﻘﺪﻳﻢ اﻟﺪﻋﻢ إﱃ اﳌﻨﻈﻤﺔ \n١– \n)اﳌﺒﺪءان اﻟﺘﻮﺟﻴﻬﻴﺎن ٢ و٧(؛\nأداء اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ واﻻﺧﺘﺼﺎﺻﺎت اﻟﻨﻮﻋﻴﺔ ﺑﺎﻻﺳﺘﻌﺎﻧﺔ ﺑﺎﻟﺪﻋﻢ اﳌﺎﱄ اﻟﺬي ﺗﻮﻓﺮه اﳌﺼﺎدر \n٢– \nاﻟﺤﻜﻮﻣﻴﺔ ﻓﻘﻂ و/ أو أي ﻣﺼﺎدر أﺧﺮى ﻏري ﺗﺠﺎرﻳﺔ؛\nاﺳﺘﻌامل آﻟﻴﺔ اﳌﻨﻈﻤﺔ ﻟﺘﺘﺒﻊ ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻟﺘﺴﺠﻴﻞ اﺳﺘﻼم وﻧﻘﻞ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ \n٣– \nﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ )اﳌﺒﺪأ اﻟﺘﻮﺟﻴﻬﻲ ٨(؛\nاﻟﺘﻘﻴﺪ ﺑﺎﻻﺗﻔﺎق* اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد اﳌﻨﺒﺜﻖ ﻋﻦ اﻹﻃﺎر اﻟﺨﺎص ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﻟﺘﺒﺎدل \n٤– \nﻓ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the core terms of reference for WHO collaborating centres for influenza, covering coordination with the WHO global influenza programme, virus characterisation, candidate vaccine development, training and support to national centres. It also requires them to acknowledge contributors in publications according to editorial guidelines.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-025",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا",
      "pageStart": 55,
      "pageEnd": 57,
      "target": "../sections/sec-025-اﳌﺮاﻛﺰ-اﻟﻮﻃﻨﻴﺔ-اﳌﻌﻨﻴﺔ-ﺑﺎﻷﻧﻔﻠﻮﻧﺰا.md",
      "narrative": null,
      "content": "اﻻﺧﺘﺼﺎﺻﺎت اﳌﺘﻌﻠﻘﺔ ﺑﺎﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ\nاﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\nاﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ\n ﺗُﻌﺪ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ آﻟﻴﺔ ﻋﺎﳌﻴﺔ ﻟﻠﺘﺤﺬﻳﺮ\nإﱃ ﻇﻬﻮر ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ذات اﻟﺴامت اﻟﻼﻓﺘﺔ، مبﺎ ﰲ ذﻟﻚ اﻟﻔريوﺳﺎت اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ. وﻓﻴام \nﻳﺘﻌﻠﻖ ﺑﺎﻷﻧﺸﻄﺔ ذات اﻟﺼﻠﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺗﻀﻢ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ أرﺑﻊ ﻓﺌﺎت ﻣﺘﻜﺎﻣﻠﺔ ﻣﻦ اﳌﺆﺳﺴﺎت \nواﳌﺨﺘﱪات، أﻻ وﻫﻲ: اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا، واﳌﺮاﻛﺰ اﳌﺘﻌﺎوﻧﺔ ﻣﻊ اﳌﻨﻈﻤﺔ، واﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ \n، واﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ. وﺑﺮﻧﺎﻣﺞ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻲ ﺑﺸﺄن H5 اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻟﻨﻤﻂ\nاﻷﻧﻔﻠﻮﻧﺰا ﻫﻮ اﻟﺬي ﻳﻨﺴﻖ أﻋامل ﺷﺒﻜﺔ اﳌﻨﻈﻤ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Terms of reference for national influenza centres in handling PIP biological materials, including sending samples to WHO laboratories and sharing sequence data.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-026",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "pageStart": 57,
      "pageEnd": 59,
      "target": "../sections/sec-026-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ.md",
      "narrative": null,
      "content": "اﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا ﻫﻲ ﻣﺨﺘﱪات ﺗﺴﺘﻮﰲ اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ اﳌﺬﻛﻮرة أدﻧﺎه. واﳌﺮﻛﺰ اﻟﻮﻃﻨﻲ\nاﳌﻌﻨﻲ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا ﻫﻮ اﳌﺮﻛﺰ اﻟﺬي ﺗﻌﻴﻨﻪ وزارة اﻟﺼﺤﺔ ﰲ اﻟﺒﻠﺪ اﳌﻌﻨﻲ وﺗﻌﱰف ﺑﻪ اﳌﻨﻈﻤﺔ. وﻳﺠﻮز أن ﺗﻜﻮن ﻟﻠﻤﺮﻛﺰ \nاﻟﻮﻃﻨﻲ اﳌﻌﻨﻲ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﺰاﻣﺎت إﺿﺎﻓﻴﺔ مبﻮﺟﺐ ﺳﻠﻄﺔ وزارة اﻟﺼﺤﺔ اﻟﺘﺎﺑﻊ ﻟﻬﺎ.\nأﻟﻒ: اﻟﴩوط اﻟﻌﺎﻣﺔ واﻷﻧﺸﻄﺔ\nاﻟﻌﻤﻞ ﰲ إﻃﺎر اﻟﺘﻨﺴﻴﻖ اﻟﺬي ﻳﺘﻮﻻه ﺑﺮﻧﺎﻣﺞ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻲ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا، وﺗﻘﺪﻳﻢ اﻟﺪﻋﻢ إﱃ اﳌﻨﻈﻤﺔ \n١– \n)اﳌﺒﺪءان اﻟﺘﻮﺟﻴﻬﻴﺎن ٢ و٧(؛\nاﺳﺘﻌامل آﻟﻴﺔ اﳌﻨﻈﻤﺔ ﻟﺘﺘﺒﻊ ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻟﺘﺴﺠﻴﻞ اﺳﺘﻼم وﻧﻘﻞ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ \n٢– \nﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ )اﳌﺒﺪأ اﻟﺘﻮﺟﻴﻬﻲ ٨(؛\nاﻟﺘﻘﻴﺪ ﺑﺎﻻﺗﻔﺎق* اﳌﻮﺣﺪ ﻟﻨﻘﻞ اﳌﻮاد اﳌﻨﺒﺜﻖ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the core terms of reference for national influenza centres, designated by health ministries and recognised by WHO, covering virus collection, testing, reporting and acknowledging contributors in publications.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-027",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "H5 اﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻟﻨﻤﻂ",
      "pageStart": 59,
      "pageEnd": 59,
      "target": "../sections/sec-027-h5-اﳌﺨﺘﱪات-اﳌﺮﺟﻌﻴﺔ-اﻟﺘﺎﺑﻌﺔ-ﻟﻠﻤﻨﻈﻤﺔ-واﳌﻌﻨﻴﺔ-ﺑﺎﻟﻨﻤ.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-028",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﳌﺘﻌﻠﻘﺔ ﺑﺎﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ",
      "pageStart": 59,
      "pageEnd": 61,
      "target": "../sections/sec-028-اﻻﺧﺘﺼﺎﺻﺎت-اﳌﺘﻌﻠﻘﺔ-ﺑﺎﻟﺘﻌﺎﻣﻞ-ﻣﻊ-اﳌﻮاد-اﻟﺒﻴﻮﻟﻮﺟﻴﺔ-ا.md",
      "narrative": null,
      "content": "اﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\nاﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ\n ﺗُﻌﺪ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ آﻟﻴﺔ ﻋﺎﳌﻴﺔ ﻟﻠﺘﺤﺬﻳﺮ إﱃ ﻇﻬﻮر\nﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ذات اﻟﺴامت اﻟﻼﻓﺘﺔ، مبﺎ ﰲ ذﻟﻚ اﻟﻔريوﺳﺎت اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ. وﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺎﻷﻧﺸﻄﺔ \nذات اﻟﺼﻠﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺗﻀﻢ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ أرﺑﻊ ﻓﺌﺎت ﻣﺘﻜﺎﻣﻠﺔ ﻣﻦ اﳌﺆﺳﺴﺎت واﳌﺨﺘﱪات، أﻻ وﻫﻲ: \nاﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا، واﳌﺮاﻛﺰ اﳌﺘﻌﺎوﻧﺔ ﻣﻊ اﳌﻨﻈﻤﺔ، واﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ \n، واﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ. وﻳﺘﻮﱃ ﺑﺮﻧﺎﻣﺞ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻲ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا ﺗﻨﺴﻴﻖ أﻋامل H5 ﺑﺎﻟﻨﻤﻂ\nﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ. وﰲ إﻃﺎر ﻛﻞ ﻓﺌﺔ ﺗﺆدي ﺟﻤﻴﻊ اﳌﺆﺳﺴﺎت واﳌﺨﺘﱪات اﻟﻮﻇ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Terms of reference for WHO H5 reference laboratories in handling PIP biological materials, repeating the network description and duties on sharing materials and sequence data.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-029",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "pageStart": 61,
      "pageEnd": 63,
      "target": "../sections/sec-029-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ.md",
      "narrative": null,
      "content": "ﻫﻲ ﻣﺨﺘﱪات ﻳﺘﻢ ﺗﻌﻴﻴﻨﻬﺎ مبﻮﺟﺐ إﺟﺮاءات ﻣﺤﺪدةH5 اﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻟﻨﻤﻂ\nﺗﻀﻌﻬﺎ اﳌﻨﻈﻤﺔ، وﻋﲆ أﺳﺎس ﻇﺮﰲ، وﺗﻔﻲ ﺑﺎﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ اﻟﻮاردة أدﻧﺎه.\nأﻟﻒ: اﻟﴩوط اﻟﻌﺎﻣﺔ واﻷﻧﺸﻄﺔ\n:H5 اﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ ﺑﺎﻟﻨﻤﻂ\nاﻟﻌﻤﻞ ﰲ إﻃﺎر اﻟﺘﻨﺴﻴﻖ اﻟﺬي ﻳﺘﻮﻻه ﺑﺮﻧﺎﻣﺞ اﳌﻨﻈﻤﺔ اﻟﻌﺎﳌﻲ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا، وﺗﻘﺪﻳﻢ اﻟﺪﻋﻢ إﱃ اﳌﻨﻈﻤﺔ \n١– \n)اﳌﺒﺪأ اﻟﺘﻮﺟﻴﻬﻲ ٢(؛\n ﺑني اﻟﺒﴩ؛H5 اﺳﺘﻴﻔﺎء ﻣﻌﺎﻳري اﳌﻨﻈﻤﺔ ﺑﺸﺄن ﻗﺒﻮل اﻟﻨﺘﺎﺋﺞ اﻹﻳﺠﺎﺑﻴﺔ ﻟﻠﻌﺪوى ﺑﺎﻟﻔريوس ﻣﻦ اﻟﻨﻤﻂ\n٢– \nاﺳﺘﻌامل آﻟﻴﺔ اﳌﻨﻈﻤﺔ ﻟﺘﺘﺒﻊ ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻟﺘﺴﺠﻴﻞ اﺳﺘﻼم وﻧﻘﻞ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ اﻟﺨﺎﺻﺔ \n٣– \nﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ )اﳌﺒﺪأ اﻟﺘﻮﺟﻴﻬﻲ ٨(؛\nاﻟﺘﻘﻴﺪ ﺑﺎﻻﺗﻔﺎق اﳌﻮﺣﺪ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the core terms of reference for WHO H5 reference laboratories, designated case by case, including working under WHO's global influenza programme, testing H5 viruses and acknowledging contributing laboratories and countries.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-030",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ",
      "pageStart": 63,
      "pageEnd": 65,
      "target": "../sections/sec-030-اﳌﺨﺘﱪات-اﻟﺘﻨﻈﻴﻤﻴﺔ-اﻷﺳﺎﺳﻴﺔ.md",
      "narrative": null,
      "content": "اﻻﺧﺘﺼﺎﺻﺎت اﳌﺘﻌﻠﻘﺔ ﺑﺎﻟﺘﻌﺎﻣﻞ ﻣﻊ اﳌﻮاد اﻟﺒﻴﻮﻟﻮﺟﻴﺔ\nاﻟﺨﺎﺻﺔ ﺑﺎﻟﺘﺄﻫﺐ ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ\nاﳌﻌﻠﻮﻣﺎت اﻟﻌﺎﻣﺔ\n ﺗُﻌﺪ اﻟﺸﺒﻜﺔ اﻟﻌﺎﳌﻴﺔ ﻟﱰﺻﺪ اﻷﻧﻔﻠﻮﻧﺰا واﻟﺘﺼﺪي ﻟﻬﺎ اﻟﺘﺎﺑﻌﺔ ﳌﻨﻈﻤﺔ اﻟﺼﺤﺔ اﻟﻌﺎﳌﻴﺔ آﻟﻴﺔ ﻋﺎﳌﻴﺔ ﻟﻠﺘﺤﺬﻳﺮ ﻣﻦ ﻇﻬﻮر\nﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ذات اﻟﺴامت اﻟﻼﻓﺘﺔ، مبﺎ ﰲ ذﻟﻚ اﻟﻔريوﺳﺎت اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ. وﻓﻴام ﻳﺘﻌﻠﻖ ﺑﺎﻷﻧﺸﻄﺔ \nذات اﻟﺼﻠﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ ﺗﻀﻢ ﺷﺒﻜﺔ اﳌﻨﻈﻤﺔ أرﺑﻊ ﻓﺌﺎت ﻣﺘﻜﺎﻣﻠﺔ ﻣﻦ اﳌﺆﺳﺴﺎت واﳌﺨﺘﱪات، أﻻ وﻫﻲ: \nاﳌﺮاﻛﺰ اﻟﻮﻃﻨﻴﺔ اﳌﻌﻨﻴﺔ ﺑﺎﻷﻧﻔﻠﻮﻧﺰا واﳌﺮاﻛﺰ اﳌﺘﻌﺎوﻧﺔ ﻣﻊ اﳌﻨﻈﻤﺔ واﳌﺨﺘﱪات اﳌﺮﺟﻌﻴﺔ اﻟﺘﺎﺑﻌﺔ ﻟﻠﻤﻨﻈﻤﺔ واﳌﻌﻨﻴﺔ \n واﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ. واﻟﱪﻧﺎﻣﺞ اﻟﻌﺎﳌﻲ ﺑﺸﺄن اﻷﻧﻔﻠﻮﻧﺰا اﻟﺘﺎﺑﻊ ﻟﻠﻤﻨﻈﻤﺔ ﻫﻮ اﻟﺬي ﻳﻨﺴﻖ H5 ﺑﺎﻟﻨﻤﻂ\nﺷﺒﻜﺔ اﳌﻨﻈﻤ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "An Arabic annex of the Pandemic Influenza Preparedness (PIP) Framework setting out the terms of reference for WHO Global Influenza Surveillance and Response System laboratories handling PIP biological materials, starting with general information on the network's four types of laboratories. It describes the roles of essential regulatory laboratories in the network. It ends with an editor's note clarifying that references to the standard material transfer agreement mean SMTA 1. The Arabic extraction uses presentation-form characters but is legible.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-44796-ara/blocks/prose-sec-031",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ",
      "pageStart": 65,
      "pageEnd": 68,
      "target": "../sections/sec-031-اﻻﺧﺘﺼﺎﺻﺎت-اﻷﺳﺎﺳﻴﺔ.md",
      "narrative": null,
      "content": "ﻳﺠﺐ أن ﺗﺴﺘﻮﰲ اﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ ﻓﺮدﻳﺎً أو ﺟامﻋﻴﺎً اﻻﺧﺘﺼﺎﺻﺎت اﻷﺳﺎﺳﻴﺔ اﻟﻮاردة أدﻧﺎه:\nأﻟﻒ: اﻟﴩوط اﻟﻌﺎﻣﺔ واﻷﻧﺸﻄﺔ\nاﳌﺨﺘﱪات اﻟﺘﻨﻈﻴﻤﻴﺔ اﻷﺳﺎﺳﻴﺔ:\n وﻓريوﺳﺎت H5N1 إﺳﺪاء اﳌﺸﻮرة إﱃ اﳌﻨﻈﻤﺔ ﺑﺸﺄن اﺧﺘﻴﺎر ﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا ﻣﻦ اﻟﻨﻤﻂ\n١– \nاﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ، ﺑﻐﻴﺔ اﺳﺘﻌامﻟﻬﺎ ﰲ ﻟﻘﺎﺣﺎت اﻷﻧﻔﻠﻮﻧﺰا )اﳌﺒﺎدئ اﻟﺘﻮﺟﻴﻬﻴﺔ \n٢ و٣ و٥(؛\nﻣﺴﺎﻋﺪة اﳌﻨﻈﻤﺔ واﻟﺪول اﻷﻋﻀﺎء ﻋﲆ إﻋﺪاد اﻟﺠﻮاﻧﺐ ذات اﻟﺼﻠﺔ ﺑﺎﻟﻠﻘﺎﺣﺎت ﻣﻦ ﺧﻄﻂ اﻟﺘﺄﻫﺐ \n٢– \nواﻟﺘﺼﺪي ﻟﻸﻧﻔﻠﻮﻧﺰا اﻟﺠﺎﺋﺤﺔ )اﳌﺒﺎدئ اﻟﺘﻮﺟﻴﻬﻴﺔ ٢ و٣ و٤ و٧(؛\nإﺳﺪاء اﳌﺸﻮرة إﱃ اﳌﻨﻈﻤﺔ ﺑﺸﺄن اﻟﺠﻮاﻧﺐ اﻟﺘﻨﻈﻴﻤﻴﺔ واﻟﺠﻮاﻧﺐ اﻟﺨﺎﺻﺔ ﺑﺎﺳﺘﺤﺪاث اﻟﻠﻘﺎﺣﺎت اﳌﻀﺎدة \n٣– \n وﻓريوﺳﺎت اﻷﻧﻔﻠﻮﻧﺰا اﻷﺧﺮى اﻟﺘﻲ ﻗﺪ ﺗﺴﺒﺐ ﺟﺎﺋﺤﺔ",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists, in Arabic, the core terms of reference that essential regulatory laboratories must meet, individually or collectively, under the Pandemic Influenza Preparedness Framework: general duties such as advising WHO on selecting H5N1 and other potentially pandemic viruses for vaccines, supporting preparedness plans, using the virus traceability mechanism and complying with the Standard Material Transfer Agreement. Laboratory activities include storing and developing candidate vaccine viruses, preparing, calibrating and supplying reference reagents and advising WHO on vaccine virus selection, while research duties cover involving and crediting scientists from originating countries; each item cites the relevant guiding principles, and the page ends with the ISBN and WHO's address.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
